Charles Zhu
Stock Analyst at LifeSci Capital
(4.83)
# 436
Out of 4,592 analysts
272
Total ratings
58.9%
Success rate
23.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBIO Crescent Biopharma | Maintained: Buy | $28 | $14.47 | +93.50% | 11 | Jul 30, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $28 | $9.01 | +210.77% | 33 | Jul 27, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $62 | $35.50 | +74.65% | 51 | Jul 27, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $263 | $187.53 | +40.24% | 28 | Jul 22, 2026 | |
| RCUS Arcus Biosciences | Maintained: Buy | $46 | $28.19 | +63.18% | 2 | Jul 20, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 | $22.76 | +75.75% | 19 | Jul 20, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $42 | $33.98 | +23.60% | 3 | Jul 18, 2026 | |
| MOLN Molecular Partners AG | Maintained: Buy | $12 | $3.93 | +205.34% | 19 | Jul 11, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $34 | $21.94 | +54.97% | 27 | Jun 29, 2026 | |
| CNTX Context Therapeutics | Maintained: Buy | $6 | $0.5994 | +901.00% | 7 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $24.17 | +123.42% | 4 | May 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $3.92 | +563.27% | 19 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.91 | +214.14% | 12 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.75 | +113.33% | 8 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $5.75 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $27.18 | n/a | 3 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $20 | $3.69 | n/a | 6 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $38.93 | n/a | 4 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $39 | $20.21 | n/a | 4 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.45 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $32.89 | n/a | 3 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $20 | $1.11 | n/a | 4 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.00 | $0.36 | n/a | 1 | Nov 29, 2022 |
Crescent Biopharma
Jul 30, 2026
Maintained: Buy
Price Target: $28
Current: $14.47
Upside: +93.50%
Kura Oncology
Jul 27, 2026
Maintained: Buy
Price Target: $28
Current: $9.01
Upside: +210.77%
IDEAYA Biosciences
Jul 27, 2026
Maintained: Buy
Price Target: $62
Current: $35.50
Upside: +74.65%
Revolution Medicines
Jul 22, 2026
Maintained: Buy
Price Target: $263
Current: $187.53
Upside: +40.24%
Arcus Biosciences
Jul 20, 2026
Maintained: Buy
Price Target: $46
Current: $28.19
Upside: +63.18%
Immunome
Jul 20, 2026
Maintained: Buy
Price Target: $40
Current: $22.76
Upside: +75.75%
Parabilis Medicines
Jul 18, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $33.98
Upside: +23.60%
Molecular Partners AG
Jul 11, 2026
Maintained: Buy
Price Target: $12
Current: $3.93
Upside: +205.34%
Zymeworks
Jun 29, 2026
Maintained: Buy
Price Target: $34
Current: $21.94
Upside: +54.97%
Context Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $6
Current: $0.5994
Upside: +901.00%
May 30, 2026
Maintained: Buy
Price Target: $54
Current: $24.17
Upside: +123.42%
May 20, 2026
Maintained: Buy
Price Target: $26
Current: $3.92
Upside: +563.27%
May 9, 2026
Maintained: Buy
Price Target: $6
Current: $1.91
Upside: +214.14%
May 2, 2026
Reiterated: Buy
Price Target: $8
Current: $3.75
Upside: +113.33%
Jun 18, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $5.75
Upside: n/a
May 24, 2024
Maintained: Buy
Price Target: $14
Current: $27.18
Upside: n/a
Jan 2, 2024
Maintained: Buy
Price Target: $12 → $20
Current: $3.69
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $26
Current: $38.93
Upside: n/a
May 9, 2023
Maintained: Buy
Price Target: $45 → $39
Current: $20.21
Upside: n/a
Mar 17, 2023
Maintained: Buy
Price Target: $5
Current: $0.45
Upside: n/a
Jan 3, 2023
Maintained: Hold
Price Target: n/a
Current: $32.89
Upside: n/a
Jan 3, 2023
Maintained: Buy
Price Target: $30 → $20
Current: $1.11
Upside: n/a
Nov 29, 2022
Initiated Coverage: Buy
Price Target: $2.00
Current: $0.36
Upside: n/a